Website News and Research

RSS

ESPG reports further leasing successes and receives good response to the public exchange offer for the 2018/2023 bond

The European Science Park Group (ESPG), a real estate company specializing in science parks, reports further leasing successes.

From The European Science Park Group (ESPG) 22 Jun 2023

INTEGRA Biosciences’ pipettes help to advance cancer drug discovery

The Institute for Cancer Research (ICR), part of the University of London, is using VIAFLO electronic pipettes from INTEGRA Biosciences to streamline its preclinical drug screening and translational medicine workflows.

From INTEGRA Biosciences 20 Jun 2023

Doctor lands in the doghouse after giving covid vaccine waivers too freely

A Tennessee doctor has lost his medical license for issuing covid-19 vaccine waivers to patients he never met in at least three states. One, it turned out, was a dog named Charlie Kraus.

16 Jun 2023

MGI partners with Xpress Genomics to advance deep single-cell RNA-sequencing technologies

MGI, a company committed to building core tools and technology to lead life science, announced the signing of a licensing agreement with Xpress Genomics, a leading Stockholm-based company specializing in automated and scalable RNA-sequencing strategies.

From MGI 16 Jun 2023

MGI and AddLife AB announce strategic collaboration for expanded distribution of MGI products* in the Nordic Region

MGI Tech Co. Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, are delighted to announce a comprehensive collaboration with AddLife AB, one of Europe's largest distributors of clinical testing and laboratory equipment, headquartered in Stockholm.

From MGI 16 Jun 2023

MGI reveals latest updates at ESHG conference in Glasgow

MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, held a Corporate Satellite Meeting and revealed significant local partnerships at the ESHG Conference in Glasgow.

From MGI 16 Jun 2023

INTEGRA Biosciences’ pipettes help to combat prostate cancer

The lab is now in the process of moving these products over to prostate cancer screening, where they are helping to improve result accuracy and turnaround times and, ultimately, support timely diagnosis and treatment.

From INTEGRA Biosciences 6 Jun 2023

Recovery from addiction is a journey. There’s no one-and-done solution.

The atmosphere inside the Allen House is easygoing as residents circulate freely through the hallways, meet in group sessions, or gather on a large outdoor patio that features a dirt volleyball court with an oversize net.

6 Jun 2023

Cure Mito Foundation releases the first-of-its-kind online resource about Leigh syndrome

The Cure Mito Foundation, a parent-led organization dedicated to advancing research and treatments for Leigh syndrome, has launched the first-of-its-kind online resource about Leigh syndrome, the most common type of pediatric mitochondrial disease.

5 Jun 2023

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

At the 2023 American Society for Clinical Oncology Annual Meeting—to be held June 2-6 in Chicago, Illinois—Fred Hutchinson Cancer Center experts will present research spanning survivorship, advances in treatments and clinical trials, how access to cancer care affects outcomes, integrative medicine and more.

5 Jun 2023

Study offers the most comprehensive archive of cellular, molecular features involved in psoriatic disease

Beneath and beyond the reddish, flaky lesions that form in the skin of those with psoriasis, mild and severe forms of the disease can be told apart by the activity of key cells and signaling pathways, a new study shows.

2 Jun 2023

Simplifying AI data analysis for scientists – as REPROCELL, IBM and STFC Hartree Centre successfully launch Pharmacology-AI platform

REPROCELL today announces the launch of a new commercial service, Pharmacology-AI.

From REPROCELL 2 Jun 2023

CardioGen upgrade facilitates more accurate diagnosis of monogenic cardiovascular diseases

Over 2,800 cases, representing a 31% increase, added to BGI Genomics-led CardioGen's hereditary cardiovascular disease gene data.

From BGI Genomics 1 Jun 2023

Breaking barriers to improve access to quality information about lupus

In general, there is an issue around the quality of information about lupus on the internet. Rumors, unchecked data, and unconfirmed research all contribute to confusion and anxiety, and can lead to people taking the wrong actions for themselves and their disease.

31 May 2023

COVID-19's shifting impact: the changing relationship between infections and severe outcomes

Exploring the dynamics of SARS-CoV-2 infection hospitalization and fatality ratios in England.

31 May 2023

ENDO 2023 news conferences to highlight latest research in diabetes, obesity, reproductive health

Researchers will delve into the latest research in diabetes, obesity, reproductive health and other aspects of endocrinology during the Endocrine Society's ENDO 2023 news conferences June 15-18.

30 May 2023

INTEGRA’s PIPETBOY Makes Pipetting Easy for Molecular Biology Techniques

INTEGRA Biosciences’ PIPETBOY acu 2 pipette controller is helping researchers in the Immune Sensing and Signaling Dynamics group/ImmunoHUB at the i3S in Porto, Portugal, to further their research into the role of the aryl hydrocarbon receptor (AHR) in infection and cancer.

From INTEGRA Biosciences 30 May 2023

Cardiovascular disease is primed to kill more older adults, especially Blacks and Hispanics

Cardiovascular disease — the No. 1 cause of death among people 65 and older — is poised to become more prevalent in the years ahead, disproportionately affecting Black and Hispanic communities and exacting an enormous toll on the health and quality of life of older Americans.

30 May 2023

OpenAI's ChatGPT shows promise as a fertility advisor, despite limitations

Researchers use fertility as a domain to test ChatGPT’s performance and assess its usage as a clinical tool.

25 May 2023

Screening delays during the COVID-19 pandemic likely to increase cancer cases

Delays in cancer screening during the COVID-19 pandemic will likely cause a significant increase in cancer cases that could have been caught earlier with screening, and may now be diagnosed at later stages, placing an increased burden on an already strained healthcare system, according to a new research article published in the Journal of the American College of Surgeons.

25 May 2023

Website News and Research

ESPG reports further leasing successes and receives good response to the public exchange offer for the 2018/2023 bond

INTEGRA Biosciences’ pipettes help to advance cancer drug discovery

Doctor lands in the doghouse after giving covid vaccine waivers too freely

MGI partners with Xpress Genomics to advance deep single-cell RNA-sequencing technologies

MGI and AddLife AB announce strategic collaboration for expanded distribution of MGI products* in the Nordic Region

MGI reveals latest updates at ESHG conference in Glasgow

INTEGRA Biosciences’ pipettes help to combat prostate cancer

Recovery from addiction is a journey. There’s no one-and-done solution.

Cure Mito Foundation releases the first-of-its-kind online resource about Leigh syndrome

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

Study offers the most comprehensive archive of cellular, molecular features involved in psoriatic disease

Simplifying AI data analysis for scientists – as REPROCELL, IBM and STFC Hartree Centre successfully launch Pharmacology-AI platform

CardioGen upgrade facilitates more accurate diagnosis of monogenic cardiovascular diseases

Breaking barriers to improve access to quality information about lupus

COVID-19's shifting impact: the changing relationship between infections and severe outcomes

ENDO 2023 news conferences to highlight latest research in diabetes, obesity, reproductive health

INTEGRA’s PIPETBOY Makes Pipetting Easy for Molecular Biology Techniques

Cardiovascular disease is primed to kill more older adults, especially Blacks and Hispanics

OpenAI's ChatGPT shows promise as a fertility advisor, despite limitations

Screening delays during the COVID-19 pandemic likely to increase cancer cases

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News